DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/dj3q2q/interventional_neu) has announced the addition of GlobalData's new report "Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" to their offering.

GlobalData's new report, Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 provides key market data on the Interventional Neurology market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment within four market categories -Embolic Systems, Navigational Systems, Aneurysm Clips and Neurovascular Stents. The report also provides company shares and distribution shares data for the overall Interventional Neurology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or oldera population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 Interventional Neurology in BRICS

4 Interventional Neurology In Brazil

5 Interventional Neurology In Russian Federation

Read more here:
Research and Markets: Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to ...

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/prl69j/north_america_neur) has announced the addition of GlobalData's new report "North America Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, North America Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the North America Neurology Devices market - Canada and United States. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope:

- Countries covered include Canada and United States.

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Neurology Devices market..

Companies Mentioned:

The rest is here:
Research and Markets: North America Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

Thats why the American Academy of Neurology became the American Brain Institute

Roger Ressmeyer/Corbis

The big news out of the recent American Academy of Neurologys 64th annual meeting in New Orleans had nothing to do with the latest wonder drug or a research breakthrough: it was the American Academy of Neurology Foundations decision to change its name to the American Brain Institute. The simplerand easier to remembermoniker is part of a larger rebranding exercise by the 20-year-old organization, wrote John Mazziotta, the chair of the foundations board of trustees.

By adopting a broader label, the institute hopes to make itself the worlds leader in raising money for research to cure brain diseasesa list that includes Alzheimers disease, stroke, Parkinsons disease, autism and epilepsy. Hence the American Brain Institutes smart new image, location (its offices moved to Saint Paul from Minneapolis, Minn.), and advertising campaign to educate neurologists, patients, caregivers and the public about the need to donate money to research to cure brain disease.

One gambit to increase coffers is selling virtual brains in honour of donors friends and relatives for as little as US$5. In replacing neurology, a term coined in 1681 by British neuroanatomist Thomas Willis, with brain, the institute is slow to the semantic trend; the NeuroScience Canada Foundation folded into Brain Canada last year. Whether neurologists will demand to be known as brainologists next remains to be seen.

Read more:
‘Brain’ beats ‘neurology’ at fundraisers

29-05-2012 02:02 Dr. Chris Cormier, DC explains Quantum Neurology and the how your nervous system is like an electrical breaker box for your body. This educational video is an ADVERTISEMENT for Dr. Chris Cormier, DC and not intended to treat, cure, or prevent any disease or illness. For more information visit Dr. Cormier's website at http://www.nervehealthinstitute.com.

Read this article:
The Nerve Health Institute - Quantum Neurology - Your Nervous System - Brain

Public release date: 28-May-2012 [ | E-mail | Share ]

Contact: Rachel Seroka rseroka@aan.com 612-928-6129 American Academy of Neurology

MINNEAPOLIS Exposure to solvents at work may be associated with reduced thinking skills later in life for those who have less than a high school education, according to a study published in the May 29, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

The thinking skills of people with more education were not affected, even if they had the same amount of exposure to solvents.

"People with more education may have a greater cognitive reserve that acts like a buffer allowing the brain to maintain its ability to function in spite of damage," said study author Lisa F. Berkman, PhD, of Harvard University in Cambridge, Mass. "This may be because education helps build up a dense network of connections among brain cells."

The study involved 4,134 people who worked at the French national gas and electric company. The majority of the people worked at the company for their entire career. Their lifetime exposure to four types of solventschlorinated solvents, petroleum solvents, benzene and non-benzene aromatic solventswas assessed. The participants took a test of thinking skills when they were an average of 59 years old and 91 percent were retired.

A total of 58 percent of the participants had less than a high school education. Of those, 32 percent had cognitive impairment, or problems with thinking skills, compared to 16 percent of those with more education. Among the less-educated, those who were highly exposed to chlorinated and petroleum solvents were 14 percent more likely to have cognitive problems than those with no exposure. People highly exposed to benzene were 24 percent more likely to have cognitive problems, and those highly exposed to non-benzene aromatic solvents were 36 percent more likely to have cognitive problems.

"These findings suggest that efforts to improve quality and quantity of education early in life could help protect people's cognitive abilities later in life," Berkman said, who worked alongside study author Erika Sabbath, ScD. "Investment in education could serve as a broad shield against both known and unknown exposures across the lifetime. This is especially important given that some evidence shows that federal levels of permissible exposure for some solvents may be insufficient to protect workers against the health consequences of exposure."

###

The study was supported by the French National Research Agency and the French Agency for Environment and Work Health Security.

See the original post here:
Working with solvents tied to cognitive problems for less-educated people

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/mbvxrd/saudi_arabia_neuro) has announced the addition of GlobalData's new report "Saudi Arabia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the Saudi Arabia Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Saudi Arabia Neurology Devices market.

- Key players covered include Medtronic, Inc., Nihon Kohden Corporation, DePuy, Inc., Natus Medical Incorporated, B. Braun Melsungen AG, CareFusion Corporation and others.

Here is the original post:
Research and Markets: Saudi Arabia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

The Mayo Clinic Patient app allows access to the latest news, publications, and health information from Mayo Clinic. Mayo Clinic patients also have access to their personal medical record, appointment schedule and other services using their Patient Online Services account.

The Mayo Clinic Patient app provides local community information, including directions to local restaurants, entertainment, and more. http://youtu.be/UAymmf5ZUNo

Source:
http://feeds.feedburner.com/CasesBlog

Hemophilia belongs to a family of inherited lifelong bleeding conditions that prevent blood from clotting properly. Patients with these disorders bleed for longer than normal, either as a result of injury or spontaneously without an external cause.

The severity of bleeding depends on the amount of clotting factor that is missing or not functioning properly, which in hemophilia A and B - the most common types of hemophilia - is the coagulation factors VIII and IX, respectively.

In addition to external bleeding, patients more commonly have internal bleeding around the joints and muscles, which can be extremely painful and cause permanent disability. Bleeding into major organs such as the brain is especially difficult to manage and can be fatal.

Here are 2 hemophilia educational videos by CDC:  Playing it Safe With Hemophilia: Friends with hemophilia talk about playing sports growing up and the importance of making smart decisions.

Starting the Conversation: Hemophilia. How to talk to your friends about hemophilia. A group of friends ask their friend Billy questions about his hemophilia:

Hemophilia care has undergone substantial improvements during the past 40 - 50 years. Early clotting factor concentrates were not sufficiently refined to enable self-administered treatment at home until the 1970s.

Long-term substitution therapy (prophylaxis) of the missing clotting factor is the recommended treatment in severe hemophilia. The major side-effect of treatment, development of inhibitors to the infused concentrate, is the main threat to the health of patients.

Mnemonic: Differential Diagnosis of Bleeding Disorders: F-CAP

Fibrinolysis - tPA
Coagulopathy - hemophilia, vWD
Angiopathy - conditions affecting blood vessels, e.g. Osler-Weber-Rendu syndrome
Platelets - thrombocytopenia or thrombocytopathia

Initial diagnostic tests = 3P:

Platelets
PT - INR
PTT

References:

http://www.cdc.gov/NCBDDD/video/Hemophilia_sports/index.html

http://www.cdc.gov/NCBDDD/video/Hemophilia_Friends/index.html

Making haemophilia a global priority - The Lancet, 2012.

Modern haemophilia care - The Lancet, 2012.

Source:
http://feeds.feedburner.com/CasesBlog

Here are some excerpts from the Baylor College of Medicine commencement address by Dr. Eric Topol, director of the Scripps Translational Science Institute, delivered yesterday, May 22, 2012. This should be a required reading for everyone involved in healthcare, which is basically everybody because each and every one of us will be a patient one day.

Eric Topol to medical students: "When I was in medical school, the term "digital" was reserved for the rectal examination."

"You sleep with your cell phone and prize it right up there with food and water. We have evolved to a new species of man. We are Homo distractus!"

The benefits of digital medicine are clear to Dr. Topol who shares the story of a patient he saw last week: "I asked him to put his fingers on the 2 sensors on the back of my iPhone case so I could do his electrocardiogram—ECG—that was normal. And free, by the way. Then instead of using a stethoscope to listen to his heart, I used a portable pocket-sized high-resolution ultrasound device and within a minute I could see every heart structure—the heart muscle thickness and function, the valves, the size of the 4 chambers. Why would I ever listen for lub-dub when I can see everything? I haven't used a stethoscope for over 2 years to listen to a patient's heart."

Here is Eric Topol's presentation at Health at Google:

References:

Baylor College of Medicine commencement address by Dr. Eric Topol, director of the Scripps Translational Science Institute

Comments from Twitter

Quoc-Dien Trinh, MD @qdtrinh: Makes it sound cool. “@DrVes: Dr Topol to med studs: When I was in med school, the term "digital" was reserved for the rectal examination"

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/cvtj9c/united_kingdom_neu) has announced the addition of GlobalData's new report "United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the United Kingdom Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Accuray Incorporated, DePuy, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Reasons to buy

Read the original:
Research and Markets: United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/m2g8x4/switzerland_neurol) has announced the addition of Global Markets Direct's new report "Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Switzerland Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Switzerland Neurology Devices market.

Companies Mentioned

See the rest here:
Research and Markets: Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Out Now

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--

According to a recent study published online in Neurology, Omega-3 fatty acids, like those found in Omega XL fish oil extract containing DHA and EPA from the New Zealand green-lipped mussel, may provide more benefits for elderly people suffering from Alzheimers.

According to the study, Researchers for the Neurology study examined the health and diet of 1,219 people, 65 years of age, who did not have dementia. The individuals were part of the Washington Heights/Hamilton Heights Columbia Aging Project.

Data show that consuming one gram of omega-3 fatty acids each day (equivalent to eating about half a filet of salmon) is associated with 20% to 30% lower blood beta-amyloid levels. According to the study authors, in Alzheimers disease, those protein fragments are thought to accumulate in the brain and form plaque. The plaque contributes to nerve cell damage in the brain and leads to the symptoms of Alzheimers.

The brain itself is made up mostly of fatty acids; the most predominant, making up 40% of these fatty acids, is Docosahexaenoic acid (DHA), the other is Eicosapentaenoic acid (EPA). EPA and DHA are referred to as omega-3 essential fatty acids (EFAs). Omega-3 EFAs have been found to have significant health benefits, especially for the brain.

Other studies have reported that long-term treatment of EPA improved an age-related reduction in blood flow in the brain and increased glucose metabolism.

Omega XL is a bestselling Omega 3 essential fatty acid supplement that contains the patented stabilized marine lipid extract PCSO-524 derived only from the New Zealand green-lipped mussel. Omega XL, manufactured exclusively by Great HealthWorks Inc., is the only omega-3 fish oil supplement available in the US that contains the potent PCSO-524 marine lipid extract. To find more information about Omega XL and PCSO-524 visit http://www.OmegaXL.com.

Source: Neurology

Gu Y, et al "Nutrient intake and plasma beta-amyloid" Neurology 2012; 78: 1-9.

About Great HealthWorks, Inc.

See the rest here:
Great HealthWorks Announces New Study: Omega-3s May Benefit Brain Proteins Linked to Alzheimer’s

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/bbn634/canada_neurology_d) has announced the addition of GlobalData's new report "Canada Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the Canada Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Canada Neurology Devices market.

- Key players covered include Medtronic, Inc., DePuy, Inc., Stryker Corporation, Cadwell Laboratories, Inc., Integra LifeSciences Holdings Corporation, CareFusion Corporation and others.

Reasons to buy

View original post here:
Research and Markets: Canada Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

Here are my suggestions for some of the top articles related to healthcare social media in the past 2 weeks:

Social media “likes” healthcare: From marketing to social business. Social media and health care: opportunities and obstacles - PWC 2012 report, free download http://goo.gl/GtSgE

8 Chrome Extensions that Make Blogging Easier http://goo.gl/fFKye

"News Squares" for Chrome is a new visual RSS reader http://goo.gl/ZgO7Z

CDC Social Media Guidelines and Best Practices http://goo.gl/Sw0n - Twitter guide updated in Feb 2012.

"20 Days to High-Quality, Engaged Twitter Following (in just 20 minutes a day)" http://goo.gl/8T0xL - Mixed bag of advice, some good tips

There is an allergy/immunology wiki: "AI notes" http://goo.gl/Qt1iE - Not sure who's behind it, looks useful.

Medicine, Social Media and Clinical Excellence. Let’s do it. http://goo.gl/WgRDw -- Here is one of my related blog posts: Doctors are natural communicators - social media is extension of what they do every day http://goo.gl/2FzQb

Study: There is a kernel of truth to the popular term "Facebook stalking". Introducing new terms (to me) such as: cyber obsessional pursuit (COP) and obsessive relational pursuit (ORI), which are categories of cyberstalking and stalking, resulting in three factors: Covert Provocation, Public Harassment, and Venting. http://goo.gl/sgVys

How to find RSS feeds for Twitter accounts, Facebook pages, YouTube, other SoMe sites http://goo.gl/Q6tNg

Fake tweet stops Nashville doctor's lecture, plans for cruise http://goo.gl/Lj0mO

How to Create Your Own Website using Blogger - Step-by-Step Guide for Physicians http://goo.gl/tCd37

Science blogging and self-promotion? http://goo.gl/yGUqS

How To Deal With Information Overload http://goo.gl/h4CmL and http://goo.gl/wDv5

The articles were selected from my Twitter and Google Reader streams. Please feel free to send suggestions for articles to allergycases@gmail.com and you will receive acknowledgement in the next edition of this publication.

Source:
http://feeds.feedburner.com/CasesBlog

What is "the favorite" for medical students in the UK at the moment? Going into General Practice (at minute 2:45 of the video). They are also "very keen into going into a specialty such as pediatrics". This is a night and day difference compared to their counterparts in the U.S.

From Cambridge University YouTube channel: "At Cambridge, we offer two medicine courses - the Standard Course and the Graduate Course. With both, our aim is to educate students to become compassionate, thoughtful, skilled members - and leaders - of the medical profession.

Success in medicine requires application and hard work, both while studying and when in practice. However, it brings great rewards in terms of job satisfaction, involving as it does a combination of science and human interactions, and numerous career opportunities."

To find out more about Medicine at Cambridge, see http://study.cam.ac.uk/undergraduate/courses/medicine

Comments from Twitter:

Nick Bennett @peds_id_doc: Best medical school in the world. Seriously.

Medical School Life in Cambridge and Debrecen - @Berci compares the promotional videos http://goo.gl/BZm2w

Source:
http://feeds.feedburner.com/CasesBlog

Graham Walker is one of the first medical bloggers. He went on a hiatus during his emergency medicine (EM) residency, and has now found new inspiration to blog as an EM attending at Stanford University medical center. This is his talk on social media and medicine at Stanford University Grand Rounds: http://youtu.be/qtkggenLmlE

Dr. Walker: This is my talk on the dissemination of medical information over time, how the internet and social networking are changing medicine, and how to use digital tools to be a better clinician at the bedside.

Here is Graham's list of Digital Tools to Improve the Specialty:
http://gmergency.tumblr.com/post/22727728700/stanford-grand-rounds-may-9-2012

Comments from Twitter:

Alice Ackerman, MD, @CloseToHomeMD: [You need to watch the video-Gr8 talk]

Source:
http://feeds.feedburner.com/CasesBlog

From American Family Physician:

Depression affects up to 9% of U.S. population.

The U.S. Preventive Services Task Force recommends screening in adolescents and adults but it does not recommend screening for depression in children 7-11 years of age, or screening for suicide risk in the general population.

The Patient Health Questionnaire (PHQ)-2 and PHQ-9 are commonly used and validated screening tools.

The PHQ-2 has a 97% sensitivity and 67% specificity in adults. The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past 2 weeks, scoring each as 0 ("not at all") to 3 ("nearly every day").

PHQ-9 has a 61% sensitivity and 94% specificity in adults. The PHQ-9 depression module scores each of the 9 DSM-IV criteria as “0” (not at all) to “3” (nearly every day).

If the PHQ-2 is positive for depression, the PHQ-9 should be administered.

In older adults, the 15-item Geriatric Depression Scale is an appropriate follow-up test.

If these screening tests are positive for depression, further evaluation is needed to confirm that the patient's symptoms meet the Diagnostic and Statistical Manual of Mental Disorders' (DSM) criteria for diagnosis.

References:

Screening for depression. Maurer DM. Am Fam Physician. 2012 Jan 15;85(2):139-44.

Image source: Vincent van Gogh's 1890 painting At Eternity's Gate. Wikipedia, public domain.

Source:
http://feeds.feedburner.com/CasesBlog

The “Best of Medical Blogs - BMB weekly review and blog carnival” is a weekly summary of the best posts from medical blogs. Feel free to send your suggestions to my email at clinicalcases@gmail.com. Best of Medical Blogs (BMB) is published every Tuesday, just like the old Grand Rounds.

A Medical Educator Joins Social Media: One Year Later

Dr. Djuricich, Program Director in Medicine-Pediatrics at the Indiana University, shares what he has learned in one short year: If physicians and other health care professionals are not becoming involved in social media, they are missing out on a “place” where many of the patients already are. There is a lot of misinformation floating around on the internet. It is a duty of physicians to combat this and provide correct information. Do not let social media take over your life. The important things (family, friends, etc.) are still the important things, so don’t lose the priorities. http://goo.gl/zNfpe

What explains blogging longevity? It's easy: blog for yourself, and share with others

Dr. Centor explains his blogging longevity after 10-years of blogging. I've been blogging for 8 years, and I agreee with him: Why you should write a blog for yourself rather than for a shifting audience http://goo.gl/P8xtz

Here's Dr. Centor again: Explaining longevity is subjective. Mostly, I like blogging. Basically I blog with myself in mind, and am gratified that others find my comments interesting. Blogging is never a chore. One cannot last 10 years doing a chore. http://goo.gl/Jyl2o

Cardiologist Dr. Wes nominates the hardest to read Abstract of the Year at 2012 Heart Rhythm Society

What is the abstract that contributes the smallest amount to our field while demonstrating the worst grammar, the most bureaucratic lingo and, of course, verbosity. The sentence that clinched it? "Conclusions: The harmonization of endpoint definitions, terminology, and clinical trial design paradigms provides consistency across clinical trial studies that can facility (sic) clinician acceptance of results and the evaluation of safety and effectiveness of devices and medicines for atrial fibrillation." http://goo.gl/ZstA0

Harvard Medical School Q&A blog doctor reflects on his readers’ feedback

Dr. Komaroff from the blog Ask Doctor K.: “Since I began this column last September, I’ve received a lot of mail — both emails and “snail mail.” Mostly it’s been health questions. I can’t answer them all, but I try to answer as many as I can. However, I’ve also received complaints. Sometimes they represent an honest difference of perspective. On occasion, they reflect the fact that I’m a man.” http://goo.gl/XK3O1

A complete list of all academic medical journals available for the iPad

The omnipresent blog iMedicalApps makes a good use of Google Docs spreadsheet to list the apps of many academic medical journals available for the iPad. I still have personal preference for the open web rather than apps but that’s just me. http://goo.gl/13Gjz

What is postinfectious cough and how to treat it?

From Dr. Matthew Mintz' blog: While the cause of the postinfectious cough is not known, it has been thought to be due to the extensive damage of cells lining the lung and widespread airway inflammation of the upper and/or lower airways. The good news is that this usually goes away by itself, the bad news is that it can take weeks or even months, and can be quite disruptive to patients lives. Since symptoms are caused primarily by inflammation and hyperresponsiveness/bronchoconstriction in the lungs (which is what we see in asthma), then treatment is likely best with something that treats both inflammation and bronchoconstriction in the lungs, such as an inhaled corticosteroid/long-acting beta agonist like Advair (which is commonly used in asthma). Use of Advair for postinfectious cough may be the single most common off-label use of any prescription product. Since inflammation can persist for weeks, it is important that Advair be used for at least 4 weeks. If symptoms return, the patient should be brought back for pulmonary function testing as this may be a new presentation of asthma. http://goo.gl/RgxLb

Reality Social Media: Live Tweeting Brain Surgery. What is the downside of this marketing push? Dr. Wes explains: http://goo.gl/XbKwv

"Healthcare Going To The Dogs" - a video for training hospital administrators http://goo.gl/hv40a and http://goo.gl/xsW4J

Science blogging and self-promotion? http://goo.gl/yGUqS

Source:
http://feeds.feedburner.com/CasesBlog

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0862102/United-Kingdom-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories.- Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devicesmarket. - Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Accuray Incorporated, DePuy, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the United Kingdom Neurology Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 102 Introduction 132.1 What is This Report About? 133 Neurology Devices In United Kingdom 143.1 Neurology Devices, Market Segmentation 143.2 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 153.3 Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2011 173.4 Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 183.5 Neurology Devices, United Kingdom, Company Share (2010-2011) 244 CSF Management In United Kingdom 264.1 CSF Management, Market Segmentation 264.2 CSF Management Market, United Kingdom, Revenue Mix ($m), 2011 274.3 CSF Management Market, United Kingdom, Segment Contribution (%), 2011 284.4 CSF Management Overall Revenue, (2004-2018) 294.5 CSF Management Overall Volume (2004-2018) 334.6 CSF Management Average Price (2004-2018) 354.7 CSF Management Distribution Share (2010-2011) 354.8 CSF Management, United Kingdom, Company Share (2010-2011) 365 Interventional Neurology In United Kingdom 385.1 Interventional Neurology, Market.Segmentation 385.2 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2011 395.3 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 405.4 Interventional Neurology Overall Revenue, (2004-2018) 415.4.1 Embolic Systems Revenue (2004-2018) 455.4.2 Navigational Systems Revenue (2004-2018) 495.5 Interventional Neurology Overall Volume (2004-2018) 535.5.1 Embolic Systems Volume (2004-2018) 575.5.2 Navigational Systems Volume (2004-2018) 595.6 Interventional Neurology Average Price (2004-2018) 615.7 Interventional Neurology Distribution Share (2010-2011) 625.8 Interventional Neurology, United Kingdom, Company Share (2010-2011) 636 Neurological Diagnostic Equipment In United Kingdom 656.1 Neurological Diagnostic Equipment, Market.Segmentation 656.2 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2011 666.3 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 676.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 686.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 726.6 Neurological Diagnostic Equipment Average Price (2004-2018) 766.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 776.8 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011) 787 Neurostimulation Devices In United Kingdom 807.1 Neurostimulation Devices, Market Segmentation 807.2 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2011 817.3 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 827.4 Neurostimulation Devices Overall Revenue, (2004-2018) 837.5 Neurostimulation Devices Overall Volume (2004-2018) 877.6 Neurostimulation Devices Average Price (2004-2018) 917.7 Neurostimulation Devices Distribution Share (2010-2011) 927.8 Neurostimulation Devices, United Kingdom, Company Share (2010-2011) 938 Neurosurgical Products In United Kingdom 948.1 Neurosurgical Products, Market Segmentation 948.2 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2011 958.3 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 968.4 Neurosurgical Products Overall Revenue, (2004-2018) 978.5 Neurosurgical Products Overall Volume (2004-2018) 1018.6 Neurosurgical Products Average Price (2004-2018) 1038.7 Neurosurgical Products Distribution Share (2010-2011) 1038.8 Neurosurgical Products, United Kingdom, Company Share (2010-2011) 1049 Radiosurgery In United Kingdom 1059.1 Radiosurgery, Market Segmentation 1059.2 Radiosurgery Market, United Kingdom, Revenue Mix ($m), 2011 1069.3 Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 1079.4 Radiosurgery Overall Revenue, (2004-2011) 1089.5 Radiosurgery Overall Volume (2004-2011) 1109.6 Radiosurgery Average Price (2004-2011) 1119.7 Radiosurgery Distribution Share (2010-2011) 1119.8 Radiosurgery, United Kingdom, Company Share (2010-2011) 11210 Overview of Key Companies in United Kingdom Neurology Devices Market 11310.1 Medtronic, Inc. 11310.1.1 Company Overview 11310.1.2 Share in the United Kingdom Neurology Devices Market 11310.2 St. Jude Medical, Inc. 11410.2.1 Company Overview 11410.2.2 Share in the United Kingdom Neurology Devices Market 11410.3 Accuray Incorporated 11510.3.1 Company Overview 11510.3.2 Share in the United Kingdom Neurology Devices Market 11510.4 DePuy, Inc. 11610.4.1 Company Overview 11610.4.2 Share in the United Kingdom Neurology Devices Market 11610.5 Stryker Corporation 11710.5.1 Company Overview 11710.5.2 Share in the United Kingdom Neurology Devices Market 11710.6 B. Braun Melsungen AG 11810.6.1 Company Overview 11810.6.2 Share in the United Kingdom Neurology Devices Market 11810.7 Boston Scientific Corporation 11910.7.1 Company Overview 11910.8 Cyberonics, Inc. 11910.8.1 Company Overview 11910.9 Terumo Corporation 12010.9.1 Company Overview 12010.10 Integra LifeSciences Holdings Corporation 12010.10.1 Company Overview 12010.11 Cadwell Laboratories, Inc. 12010.11.1 Company Overview 12010.12 Natus Medical Incorporated 12110.12.1 Company Overview 12110.13 Micromed S.p.A 12110.13.1 Company Overview 12110.14 Christoph Miethke GmbH & Co. KG 12110.14.1 Company Overview 12110.15 CareFusion Corporation 12210.15.1 Company Overview 12210.16 Nihon Kohden Corporation 12210.16.1 Company Overview 12210.17 KARL STORZ GmbH & Co. KG 12310.17.1 Company Overview 12310.18 Sophysa S.A. 12310.18.1 Company Overview 12310.19 Covidien plc 12310.19.1 Company Overview 12310.20 Elekta AB 12410.20.1 Company Overview 12411 Neurology Devices Market Pipeline Products 12512 Financial Deals Landscape 13112.1 Partnerships 13112.1.1 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 13113 Recent Developments 13213.1 Government and Public Interest 13213.1.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield 13213.1.2 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise 13314 Appendix 13514.1 Definitions of Markets Covered in the Report 13614.1.1 Neurology Devices 13614.2 Research Methodology 14014.3 Secondary Research 14014.4 Primary Research 14114.5 Models 14114.6 Forecasts 14214.7 Expert Panels 14214.8 GlobalData Consulting 14214.9 Currency Conversion 14314.10 Contact Us 14314.11 Disclaimer 143

List of Tables

Table 1: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 15Table 2: Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 17Table 3: Neurology Devices, United Kingdom, Cross-Category Analysis, 2004-2018 18Table 4: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 5: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22Table 6: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 24Table 7: CSF Management Market, United Kingdom, Segment Contribution (%), 2011 27Table 8: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29Table 9: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31Table 10: CSF Management, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 32Table 11: CSF Management, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 33Table 12: CSF Management, United Kingdom, Average Price ($), Historic, 2004-2011 34Table 13: CSF Management, United Kingdom, Average Price ($), Forecast, 2011-2018 34Table 14: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34Table 15: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 36Table 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 39Table 17: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011 41Table 18: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018 43Table 19: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45Table 20: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47Table 21: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Table 22: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51Table 23: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 53Table 24: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 55Table 25: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 56Table 26: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57Table 27: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Table 28: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Table 29: Interventional Neurology, United Kingdom, Average Price ($), Historic, 2004-2011 60Table 30: Interventional Neurology, United Kingdom, Average Price ($), Forecast, 2011-2018 60Table 31: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 61Table 32: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 63Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 66Table 34: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 68Table 35: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 70Table 36: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 72Table 37: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 74Table 38: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Historic, 2004-2011 75Table 39: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Forecast, 2011-2018 75Table 40: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 76Table 41: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 78Table 42: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 81Table 43: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 83Table 44: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 85Table 45: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 87Table 46: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 89Table 47: Neurostimulation Devices, United Kingdom, Average Price ($), Historic, 2004-2011 90Table 48: Neurostimulation Devices, United Kingdom, Average Price ($), Forecast, 2011-2018 90Table 49: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91Table 50: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 92Table 51: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 95Table 52: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 97Table 53: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 99Table 54: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 100Table 55: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 101Table 56: Neurosurgical Products, United Kingdom, Average Price ($), Historic, 2004-2011 102Table 57: Neurosurgical Products, United Kingdom, Average Price ($), Forecast, 2011-2018 102Table 58: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 102Table 59: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 103Table 60: Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 106Table 61: Radiosurgery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 108Table 62: Radiosurgery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 109Table 63: Radiosurgery, United Kingdom, Average Price ($), Historic, 2004-2011 110Table 64: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 110Table 65: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 111Table 66: Neurology Devices Market Pipeline Products 124Table 67: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 130

Read this article:
United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

Newswise MINNEAPOLIS A new study suggests that head impacts experienced during contact sports such as football and hockey may worsen some college athletes ability to acquire new information. The research is published in the May 16, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

The study involved college athletes at three Division I schools and compared 214 athletes in contact sports to 45 athletes in non-contact sports such as track, crew and Nordic skiing at the beginning and at the end of their seasons. The contact sport athletes wore special helmets that recorded the acceleration speed and other data at the time of any head impact.

The contact sport athletes experienced an average of 469 head impacts during the season. Athletes were not included in the study if they were diagnosed with a concussion during the season.

All of the athletes took tests of thinking and memory skills before and after the season. A total of 45 contact sport athletes and 55 non-contact sport athletes from one of the schools also took an additional set of tests of concentration, working memory and other skills.

The good news is that overall there were few differences in the test results between the athletes in contact sports and the athletes in non-contact sports, said study author Thomas W. McAllister, MD, of The Geisel School of Medicine at Dartmouth in Lebanon, N.H. But we did find that a higher percentage of the contact sport athletes had lower scores than would have been predicted after the season on a measure of new learning than the non-contact sport athletes.

A total of 22 percent of the contact sport athletes performed worse than expected on the test of new learning, compared to four percent of the non-contact sport athletes.

McAllister noted that the study did not find differences in test results between the two groups of athletes at the beginning of the season, suggesting that the cumulative head impacts that contact athletes had incurred over many previous seasons did not result in reduced thinking and memory skills in the overall group.

These results are somewhat reassuring, given the recent heightened concern about the potential negative effects of these sports, he said. Nevertheless, the findings do suggest that repetitive head impacts may have a negative effect on some athletes.

McAllister said its possible that some people may be genetically more sensitive to head impacts.

The study was supported by the National Institutes of Health and the National Operating Committee on Standards for Athletic Equipment.

Read the original post:
Study Finds Head Impacts in Contact Sports May Reduce Learning in College Athletes